Mad money on AEGY, but the really big game in town is SKTO. The immense value of Berkeley Bio's unique breakthrough and its revolutionary implications for cancer treatment and prevention worldwide is in the earliest stages of appreciation. What Gold and Apel have achieved with the all-natural cannabinoid complex changes everything. No one even comes close to this breakthrough, and SK controls it. With SK's exclusive license of Dharmanol and its ownership of  sub BB, SK is sitting on top of the mother lode, a gold vein of incredible wealth.